Skip to main content
SpringerLink
Log in

Costs drop, when treating LGS with clobazam

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Skornicki M, et al. Budget impact analysis of antiepileptic drugs for lennox-gastaut syndrome. Journal of Managed Care Pharmacy 20: 400-6, No. 4, Apr 2014. Available from: URL: http://doi.org/2014(20)4: 400-406 [pii]

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Costs drop, when treating LGS with clobazam. PharmacoEcon Outcomes News 701, 4 (2014). https://doi.org/10.1007/s40274-014-1194-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-014-1194-3

Search

Navigation